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Purpose: To determine the relationship of illnesses and medical drug consumption with the occurrence
of trafﬁc accidents among truck and bus drivers.
Methods: This is a cross-sectional study on truck and bus drivers in Tehran, Iran. The criteria for
participating in this study were: married males over 30 years old, driving license in grade one, ﬁve years
of job experience, mental health and non-addiction license. The criterion for not participating in this
study was the lack of cooperation in responding to the questions. Six months was spent to collect the
latest ﬁve years data of driving accidents from 2011 to 2016. A total of 323 truck and bus drivers in Tehran
city and the suburbs, Iran were chosen. Among them, 112 were responsible for accidents (accident group)
while 211 were not responsible for any accidents or involved in an accident in the last ﬁve years (non-
accident group). A specially designed questionnaire was used to investigate the demographic informa-
tion, medical drug consumption, medical backgrounds and history of accidents.
Results: The results revealed that compared with healthy subjects, the occurrence of accidents among
people with diabetes (OR ¼ 2.3, p ¼ 0.001) and vision weakness (OR ¼ 1.7, p ¼ 0.020) was signiﬁcantly
higher, while that among people with cardiac (OR ¼ 0.5, p ¼ 0.002) and hypertension (OR ¼ 0.9,
p ¼ 0.048) problems was remarkably lower. Moreover, consumption of Gemﬁbrozil (OR ¼ 1.8, p ¼ 0.010)
and Glibenclamide (OR ¼ 2.2, p ¼ 0.002) drugs resulted in signiﬁcantly higher incidence of accidents than
those without.
Conclusion: Frequencies of illnesses like cardiovascular and hypertension were not higher in accident
drivers than in non-accident drivers; but diabetes, vision weakness and consumption of Gemﬁbrozil and
Glibenclamide lead to more trafﬁc accidents.
© 2019 Chinese Medical Association. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Trafﬁc accidents are one of the important general health prob-
lems in both developed and developing countries. Around the
world 1.2 million people die because of trafﬁc accidents and about
20e50 million people are either injured or disabled. The pattern of
trafﬁc accidents is different in developing and developed countries,
and every society has its own approaches and strategies to coun-
tering the accidents.1,2, Shahrekord University of
azdanirad).
cal Association.
oduction and hosting by ElsevieIn Iran, the major cause of death is accidents. Based on the 2017
survey on formal cases in forensic medicine in this country, 16 201
people died from trafﬁc accidents. Based on Central Information
and Police Trafﬁc Control of Law Enforcement Force of the Islamic
Republic of Iran, 22000 people die due to road accidents every year.
This number is almost four times greater than the world standard.3
However, the problem is not just the number of deaths that occur.
As per statistics, in every trafﬁc accident, for each death, three
persons are disabled and 10 are injured. All thementioned statistics
are only part of the consequences of driving accidents. If these
outcomes are combined with the indirect outcomes, which, based
on the standards, are in the ratio of 1:4, then the statistics become
quite alarming.4 Studies revealed that young people aged 15e30
years were affectedmost by driving accidents, and less experiencedr B.V. This is an open access article under the CC BY-NC-ND license (http://
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death.5e7
Danger evaluation, investigation, and the analyses of trafﬁc ac-
cidents show that we cannot explain all the accidents only by
determining car incidental malfunctions. It has been proven
worldwide that three important factors, i.e. human, road, and car
play an important role in the occurrence of accidents. The human
factor is more signiﬁcant as it affects 70% of the accidents.3,7
Humans are complex creatures. Many studies have been done to
recognize its characteristic behaviors in dangerous situations. In
addition, age or physical illness forces the drivers to consume
special drugs that may affect their consciousness while driving and
cause problems.8 The consumption of some drugs can reduce
drivers' reaction to acoustic and graphic stimuli; several illnesses
create restrictions for them and lead to terrible accidents. Insomnia,
tiredness, reduction in the level of alertness, and vertigo are the
outcome of medical drug consumption and physical illnesses.9 A
studywas carried out in USA on the relation among chronicmedical
conditions, medications, and automobile crashes. The results
showed that drivers with heart diseases were more probable to be
involved in car crashes caused due to their fault; another study
done in Norway had the same result. Benzodiazepine, nonsteroidal
anti-inﬂammatory drugs, angiotensin converting enzyme inhibitor,
and anticoagulants are associated with an increased risk of
involvement in at-fault car crashes.10,11 In another study, arthritis
and heart disease were associated with an increased risk of
involvement in at-fault trafﬁc crashes.12 Table 1 lists the side effects
of cardiovascular, diabetes and other drugs which may affect the
crashes.
Therefore, doctors warn that driving after the consumption of
some drugs can lead to fatal accidents. Statistics show that 62% of
drivers drive while they are drowsy and one third of them cause
accidents. Every year 1.2million peoplewere killed in crashes in the
world.13 The purpose of this study is to determine the relationship
of illnesses and medical drug consumption with the occurrence of
accidents among truck and bus drivers in Tehran, Iran and to pro-
vide acceptable approaches to prevent these issues.
Methods
Inclusion and exclusion criteria
This is a cross-sectional study in 2017, which spent six months
to collect data of accidents from 2011 to 2016. The sampling
method was simple random. The subjects who went to the occu-
pational medicine clinics in Tehran in 2016 to receive annual
healthy job card and job health checkup were selected for partic-
ipation in this study. The list of the truck and bus drivers in Tehran
and the suburbs and their health records were taken from the
occupational and environmental health center of Iran. Then, the
demographic and other data related to the inclusion criteria were
extracted.
The criteria for participating in this study were: married males
over 30 years old; driving license in grade one; ﬁve years of job
experience; mental health and non-addiction license for stimulants
such as alcohol, opium, cannabis, and methamphetamine. The
causes of accidents were taken from the police and those who
caused the accidents due to medical drug consumption were
included as subjects in the study. Based on these data, 500 subjects
were selected. Then, the drivers were informed about the purpose
of this study through telephonic calls and 396 of them agreed to
participate in the study.
In the next stage, the participants were invited to a medical
center on a speciﬁed date for interview, during which the multi-
dimensional Minnesota Multiphasic Personality Inventory(MMPI) questionnaire was adopted to conﬁrm the mental health
of drivers by clinic employees. MMPI questionnaire has 71
questions which assess the subjects from eight personality
indices, respectively the HS scale or hypochondria, D or
depression, HY or hysteria, Pd or social mental deviation, Pa or
paranoia, Pt or mental weakness, Sc or schizophrenia, and Ma or
hypomania. Then, the non-addiction certiﬁcate was requested
from subjects.14 Professional drivers in Iran are evaluated
annually and non-addiction license will be issued for the qual-
iﬁed ones.
In the third stage, the interviews were conducted and the sub-
jects were asked to complete a designed questionnaire during the
interview. Also, participants with accidents were asked to deter-
mine the tentative time before the accident that they consumed
medical drugs.15 Those who had consumed drugs up to 2 h prior to
the crash were allowed to enter the study. Participants without any
accident experience were asked about their history of medical drug
consumption and those who had regularly consumed drugs had
been included in the study.16
The criterion for not participating in this study was the lack of
cooperation in responding to the questions. In ﬁnal, 323 partici-
pants fully responded to the questions and had the entry criteria of
this study. A total of 112 subjects were guilty of causing accidents
(accident group) while 211 persons were pronounced ‘not guilty’ by
the police and were not involved in any accidents in the last ﬁve
years (non-accident group).16Measures
To better investigate the subjects, a speciﬁcally designed
questionnaire was used, which consisted of four parts: (1)
demographical and general questions, (2) questions on medical
drug consumption including some of cardiovascular, diabetes
and metabolic drugs, (3) medical backgrounds and diseases
including cardiac, diabetes, pulmonary, hypertension, vision
weakness and other diseases, and (4) history of driving accidents
with bus or truck and their causes.15,17,18 It must be noted that all
the questions were limited to the latest ﬁve years from 2011 to
2016. Question design of the ﬁrst and fourth parts was clear, but
those of the second and third parts required scientiﬁc review.
Therefore, a list of illnesses and medical drugs was provided to
researchers to check and review for the side effects of these
drugs. Then, two expert doctors and pharmacologists were
invited to discuss and select drugs to be included in the ques-
tionnaire and further give some suggestions on the prepare of
the questionnaire.
The following informationwas investigated: age, sex, height, job
background, cigarette consumption history, previous job, driving
hours in a day, medical drug consumption including some of car-
diovascular, diabetes and metabolic and other drugs, diseases
including cardiac, diabetes, pulmonary, hypertension, vision
weakness and other diseases, and history of accidents with bus and
truck (including number of accidents, the cause of accidents, the
guilty of accidents, and the time of medical drug consumption
before the accidents). Answers to questions took about 10 min. It
took about 10 min to ﬁnish all the questions.
To conﬁrm the information on the questionnaire, we checked
the drivers' illness, medical drugs consumption, physical and
mental condition through the recorded data in the national health
care insurance database. In addition, the number of drivers' acci-
dents from 2011 to 2016, the cause of accidents, and their guiltiness
were asked from trafﬁc police. Also, the cause of accidents was
taken from the police and those who caused the accidents due to
medical drug consumption were included as subjects in the study.
Table 1
Description and side effects of the drugs.
Drugs Descriptions Side effects
Insulin  To treat diabetes mellitus
 To decrease blood glucose
 Blurry vision; confusion;
tachycardia; neurological deﬁcits
Nitroglycerin  To treat high blood pressure
during surgery
 To control congestive heart
failure associated with heart attack
 To treat chest pain in certain patients
 Numbness; prickling; difﬁcult or
labored breathing; headache; tightness
in the chest; rapid heart rate; feeling faint,
dizzy; unusual tiredness or weakness; hypotension
Aspirin  To treat minor aches and pains
 To decrease the risk of stroke,
heart attack, and death associated with
stroke or heart attack
 Nausea; tachycardia; hypotension;
dizziness; seizures; confusion
Gemﬁbrozil  To help reduce cholesterol and triglycerides
in the blood.
 To treat very high cholesterol and triglyceride
levels in people with pancreatitis.
 To lower the risk of stroke, heart attack, or other
heart complications in people with high
cholesterol and triglycerides
 Headache; nausea; diarrhea;
dizziness; fatigue, vertigo;
heartburn; blurred vision
Enalapril  To treat high blood pressure in adults and
children who are at least 1 month old
 To treat congestive heart failure in adults
 To treat a disorder of the ventricles
 Blurred vision; confusion; dizziness;
faintness; unusual tiredness or weakness;
lightheadedness; chest pain
Propranolol  To treat tremors, angina (chest pain), hypertension,
heart rhythm disorders, and other heart or
circulatory conditions
 Difﬁculty with breathing; tightness
in the chest; fatigue and/or lassitude;
sleep disturbances; sleep disorder;
dyspnea; depressive symptoms
Captopril  To treat hypertension, congestive heart failure,
kidney problems caused by diabetes
 To improve survival after a heart attack.
 Chest pain; fast, pounding, or
irregular; heartbeat or pulse; low
blood pressure; troubled
breathing or wheezing; unusual tiredness
or weakness; vomiting and nausea; dizziness;
Sleep disorder; disturbed vision, dry eye, itchy eye
Levothyroxine  To regulate the body's energy and metabolism
 To treat hypothyroidism
 To treat or prevent goiter
 Chest pain or discomfort; difﬁcult or labored
breathing; extreme fatigue; fainting; fast, slow,
irregular, pounding, or racing heartbeat or pulse;
nausea; tightness in the chest; tremors; blurred or
double vision; dizziness; eye pain; severe
headache; seizures
Glibenclamide  To treat type 2 diabetes  Diarrhea; dizziness; headache; heartburn; nausea;
trouble breathing; hypoglycemia; confusion;
dizziness; feeling anxious; headache; blurred
vision; fast heart rate; loss of consciousness;
feeling unusually weak or tired
Atenolol  To treat angina (chest pain) and hypertension
 To lower the risk of death after a heart attack
 Cardiac failure; bradycardia; dizziness; fatigue;
blurred vision; confusion; difﬁcult or labored
breathing; tightness in chest; unusual tiredness
or weakness; anxiety; slow or irregular heartbeat;
dizziness; feeling tired
Adopted from: www.drugs.com and https://vsearch.nlm.nih.gov.
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In this study, the data were analyzed with the help of SPSS
(version 19) software, with a signiﬁcance of 0.05. Statistical-
descriptive tests, t-test, Chi-squared, and odds ratio were used for
data analysis. The t-test was used to investigate the difference be-
tween the variables of accident group and non-accident group. The
Chi-squared was used to test the homogeneity about the nominal
scale variables with more than two entries. Odds ratio was used to
measure the association between variables.
Ethical review
Data collection was done after the drivers gave their consent.
All the information given by the subjects were strictly conﬁdential
and were not shared with others. The information could only be
shared with special people or organizations for the promotion
of better. Ethical afﬁrmation was achieved from the ethical
committee.Results
Demographic factors in relation with the accident of drivers
are presented in Table 2, which reveals no signiﬁcant difference
between accident and non-accident group. The effects of ill-
nesses and drugs on accidents of truck and bus drivers are
respectively shown in Table 3. The results showed that the
chance of accident occurrence in people suffering from cardiac
(OR ¼ 0.5, p ¼ 0.002) and hypertension (OR ¼ 0.9, p ¼ 0.048)
diseases was less compared to that in people without; while the
chance of accident occurrence in subjects with diabetes (OR ¼
2.3, p ¼ 0.001) and vision weakness (OR ¼ 1.7, p ¼ 0.020) was
higher compared with those without the two diseases. Moreover,
the accident occurrence in people with pulmonary disease was
higher than that in people without, but the difference was not
signiﬁcant (OR ¼ 1.4, p ¼ 0.200). The illnesses such as blood
lipids, migraine, stomach disorder and gout did not play any role
in the occurrence of accidents. To the contrary, accidents were
less in people with these illnesses. Disorders like skeletal and
Table 2
Demographic factors in relation with the onset of accidents between two groups.
Group Demographic factors
Age (year) Job experience (year) Cigarette consumption daily Driving distance in a week (km) Body mass index Weight (kg)
Accident 45.1 15.6 7 3164 26.4 79
Non-accident 44.8 15.5 5 3294 26.5 80
p value 0.21 0.34 0.05 0.35 0.80 0.50
All of the data are shown on average.
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among the included drivers in the study.
The effect of medical drug consumption on accident occurrence
is represented in Table 4. The results revealed that the occurrence of
accidents among people who consumed Nitroglycerin, Aspirin,
Enalapril and Captopril was less compared to that among subjects
who did not, but the difference was not signiﬁcant. While the
occurrence of accidents among people who consumed Gemﬁbrozil
(OR ¼ 1.8, p ¼ 0.01) and Glibenclamide (OR ¼ 2.2, p ¼ 0.002) was
higher. The accidents occurred in people who consumed Insulin,
Propranolol, Levothyroxine, and Atenolol were more in comparison
with people who did not, but the difference was not signiﬁcant. The
results also revealed that the people who consumed Metformin,
Nitroglycerin, Teoﬁlin G, Salbutamol spray, andMeperazol hadmore
chance of accidents. In this study, the effects of some drugs such as
anti-histamine, Prazosin, and alcohol were not examined. Since, in
the present study, none of the drivers used these drugs. Therefore,
there was no relationship between these drugs and the accidents.
Discussion
It was observed that the drivers in both accident and non-
accident groups showed no signiﬁcant difference in risk factors of
cigarette consumption, high body mass index, and long driving
distances in a week, neither in terms of age nor job experience.
Hence, we can conclude that the parameters in the two groups are
equal and baseline differences can be omitted; and the chance of
accident occurrence is inﬂuenced by medical drug consumption
and illnesses alone.
Effect of disease
Based on the ﬁndings of this study, the chance of accident
occurrence in people with cardiac and hypertension problems wasTable 3
Illnesses and driving accidents.
Illness With accident, n (%) Without accident, n
Cardiac illness
Yes 10 (23.3) 33 (76.7)
No 102 (36.4) 178 (63.6)
Diabetes
Yes 42 (49.4) 43 (50.6)
No 70 (29.4) 168 (70.6)
Pulmonary illness
Yes 102 (34.0) 198 (66.0)
No 10 (43.5) 13 (56.5)
Hypertension
Yes 20 (34.5) 38 (65.5)
No 92 (34.7) 173 (65.3)
Vision weakness
Yes 37 (44.6) 46 (55.4)
No 75 (31.5) 165 (68.8)
Other illnesses
Yes 1 (14.3) 6 (85.7)
No 111 (35.1) 205 (64.9)signiﬁcantly less than those without. Klein et al.19 stated that car-
diovascular disease can decrease the control of drivers on the
vehicle and thereby cause an accident. Themain pathophysiological
mechanisms include disturbances of brain perfusion and general
weakness. On the other hand, the people with cardiovascular dis-
eases and hypertension problems have a tendency to take less risks
and show less emotional behavior due to their fear of sudden
strokes. Hence, they may avoid risky high speed driving and follow
the rules better. Therefore, cardiovascular and hypertension dis-
eases can have a double effect. As there are seldom studies on this,
it is recommended a study conducted on the relationship between
cardiovascular & hypertension diseases and driving behaviors.
There are some studies whose results do not match that of this
research. In Hours et al.’s study20 in 2008, the results showed that
the people with cardiac problems had fewer accidents while the
subjects with high blood pressure had more accidents. In other
studies, it was found that the people with high blood pressure had
more accidents.21,22 The reason for these results in the mentioned
studies was stated as tiredness and anxiety.20 In addition to the
factors of tiredness and anxiety, risk taking can also be an effective
reason for the cause of accidents among subjects with cardiovas-
cular diseases. Therefore, it is recommended that a study is per-
formed on a larger scale to determine the contribution of each of
these factors in the occurrence of accidents among subjects with
cardiovascular diseases.
People with blood lipids, migraine, stomach disorders, and gout
had less chance of accidents than the healthy people, but the dif-
ference was not signiﬁcant. However, Jung et al.'s study23 states
that the people with migraine caused twice the number of acci-
dents than the healthy ones do. Since the sampling was small, er-
rors are present in this study. Hence, a bigger sample size is
required. Since the drivers were under stress and did not have ac-
cess to a good diet, they were prone to diabetes. As diabetic people
have high or low glucose, which is enhanced by medical drug(%) OR 95% CI p value
0.5 025e1.11 0.002
2.3 1.4e3.8 0.001
1.4 0.6e3.5 0.200
0.9 0.5e1.7 0.048
1.7 1.06e2.9 0.020
0.3 0.03e2.5 0.230
Table 4
Drug consumption and driving accidents.
Drug consumption With accident n (%) Without accident n (%) OR 95% CI p value
Insulin 5.7 0.5e56.2 0.120
Yes 3 (75.0) 1 (25.0)
No 109 (34.2) 210 (65.8)
Nitroglycerin 0.2 0.03e2.16 0.170
Yes 1 (12.5) 7 (87.5)
No 111 (35.2) 204 (64.8)
Aspirin 0.7 0.22e2.4 0.400
Yes 4 (28.6) 10 (71.4)
No 108 (35.0) 201 (65.0)
Gemﬁbrozil 1.8 0.2e10.9 0.010
Yes 4 (100.0) 0 (0)
No 108 (33.9) 211 (66.1)
Enalapril 0.7 0.1e3.9 0.500
Yes 2 (28.6) 5 (71.4)
No 110 (34.8) 206 (65.2)
Propranolol 1.2 0.2e7.6 0.500
Yes 2 (40.0) 53 (60.0)
No 110 (34.6) 208 (65.4)
Captopril 0.9 0.08e10.4 0.700
Yes 1 (33.3) 2 (66.7)
No 111 (34.7) 209 (65.3)
Levothyroxine 2.8 0.47e17.4 0.220
Yes 3 (60.0) 2 (40.0)
No 109 (34.3) 209 (65.7)
Glibenclamide 2.2 1.3e3.8 0.002
Yes 38 (49.4) 39 (50.6)
No 74 (30.1) 172 (69.9)
Atenolol 1.1 0.4e2.5 0.400
Yes 10 (37.0) 17 (63.0)
No 102 (34.5) 194 (65.5)
Other drugs 1.1 0.5e2.4 0.430
Yes 12 (37.5) 20 (62.5)
No 100 (34.2) 191 (65.6)
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weaker vision and suffer from lower consciousness. Hence, the
chance of accident occurrence among them ismore and the relation
between this disease and accidents is signiﬁcant. The results of
Lagarde and coworkers24 and Jung et al.23 show that people with
diabetes and epilepsy caused more accidents.
The problem of vision weakness leads to more accident occur-
rence as well. Vision weakness is one of the effective obvious dis-
orders in the trafﬁc accident. People are evaluated for visual
impairment before they receive a driver certiﬁcate and they may
have a good vision. However, results of studies show that the con-
sumption of some drugs can temporarily cause the weakness and
other disorders of vision.4,25,26
People with pulmonary diseases also faced more accident
occurrence but the difference was not signiﬁcant. Tiredness and
physical weakness in people with pulmonary disease results in low
consciousness due to lack of oxygen. Drugs can directly create a
trafﬁc accident through their side effects such as impaired thinking,
dizziness, fatigue, sleepiness, nervousness, confusion, headache,
and blurred vision.24 In general, the consumption of some drugs
impair the attention and concentration of drivers on driving and
increase the reaction time that can enhance the risk and severity of
trafﬁc accident.15
Effect of drug consumption
The results of the current study showed that the drivers who
injected insulin had more chance of accident occurrence but the
difference was not signiﬁcant. Perhaps the people suffering from
diabetes have a low level of consciousness due to low glucose. The
ﬁndings of the Kennedy et al.'s study27 in 2002 showed that the
number of accidents among drivers with insulin complications wasmore than the drivers without this issue. The results showed that
the drivers who consumed Nitroglycerin, Aspirin, Enalapril, and
Captopril had less chance of accident occurrence. The ones who
consumed Gemﬁbrozil had more accidents since this drug had a
higher number of side effects like vertigo, headache, vision weak-
ness, and heartbeat disorder, which can easily lead to an accident.
When a driver, who had diabetes, consumed the above-mentioned
drugs as well, the chances of causing an accident increased as these
drugs, when consumed together, can lead to glucose reduction,
which in turn results in low levels of consciousness. The results also
revealed that the drivers who consumed Propranolol, Levothyrox-
ine, Atenolol, and other drugs like Metformin, Nitroglycerin, Teo-
ﬁlin G, Salbutamol spray, and Meperazol are exposed to a higher
risk of accident occurrence, but the difference was not signiﬁcant.
Also, a larger sample size is needed. Based on these ﬁndings, the
drivers who consumed Glibenclamide had more chance of accident
occurrence and the difference was signiﬁcant. Glibenclamide is an
antidiabetic drug. This type of drug decreases the blood glucose
level and produces hypoglycemia. The side effects of hypoglycemia
include shakiness, dizziness, confusion, drowsiness, weakness,
jerky movement, seizure, and blurred vision that these can be
effective in the crashes.25 Other results show that the consumption
of somnolent drugs (a drug that sleeps), anti-histamine, Prazosin,
and alcohol play an important role in driving accidents,27,28 in this
study, none of the drivers consumed them. The limitation of this
study was self-report.
Conclusion
The result of this study revealed that frequencies of cardiac and
vascular, and hypertension diseases were not higher in drivers with
trafﬁc accidents than in those without trafﬁc accidents while
A.H. Khoshakhlagh et al. / Chinese Journal of Traumatology 22 (2019) 142e147 147diabetes and weakened vision lead to an increase in trafﬁc acci-
dents in comparison with healthy people. It should be noted that
two factors including the more physical weakness and lower con-
sciousness from one side and less risk taking from other side can be
led to more chances of accidents. A bigger sample size is possibly
required to compare each factor separately. Among the medical
drugs consumed, Gemﬁbrozil and Glibenclamide led to more
chance of accident occurrence because of their side effects on the
central nervous system.
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